Arimidex 1 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FV5X0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,974
Award facts
- Contract value 100% obligated
- $3,974.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in a quantity of 30 units, valued at $3,974.03. The contract, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial federal contract portfolio focused on supplying medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award of Arimidex, an oncology medication, reflects the company's established capability in delivering specialty pharmaceuticals across multiple therapeutic domains. As a child contract under the broader IDC vehicle, this delivery order demonstrates the operational flexibility of the DLA Pharmaceutical Prime Vendor program in fulfilling specific medical supply requirements for military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FV5X0?
SPE2DR26FV5X0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26FV5X0 worth?
The government has obligated $3,974 on SPE2DR26FV5X0.
Is contract SPE2DR26FV5X0 an order under another contract?
Yes. SPE2DR26FV5X0 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV5X0 competed?
The extent of competition for SPE2DR26FV5X0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award